Serum biotinidase activity in children treated with valproic acid and carbamazepine

Journal of Child Neurology

Volumn 25, Issue 1, 2010, Pages 32-35

  Castro Gago, Manuel ^a   Gómez Lado, Carmen ^a   Eirís Puñal, Jesús ^a   Díaz Mayo, Isabel ^a   Castiñeiras Ramos, Daisy E ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

Author keywords

Ammonia; Biotin; Biotinidase; Carbamazepine; Hair loss; Transaminases; Valproic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BIOTIN; BIOTINIDASE; CARBAMAZEPINE; GAMMA GLUTAMYLTRANSFERASE; VALPROIC ACID;

ALOPECIA; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME BLOOD LEVEL; FEMALE; HAIR LOSS; HUMAN; HYPERAMMONEMIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT;

ALANINE TRANSAMINASE; AMMONIA; ANTICONVULSANTS; ASPARTATE AMINOTRANSFERASES; BIOTINIDASE; CARBAMAZEPINE; CHILD; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HAIR; HUMANS; HYPERAMMONEMIA; LIVER; SEIZURES; SEX CHARACTERISTICS; VALPROIC ACID;

EID: 75649101778     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809336118     Document Type: Article

References (20)

1. Wilder BJ Gastrointestinal tolerance of sodium valproate. Neurology. 1983 ; 33 (6). 808-811.
2. McKinney PA, Finkebine RD, DeVane CI Alopecia and mood stabilizer therapy. Ann Clin Psychiatry. 1996 ; 8 (3). 183-185.
3. Wallace SJ A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Saf. 1996 ; 15 (6). 379-393.
4. Dreifuss FE Valproic acid toxicity. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs. 4 th ed. New Jersey: Lippinvott-Raven Healthcare ; 1996: 641-648.
5. Ohtani Y., Endo F., Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr. 1982 ; 101 (5). 782-785.
6. Castro-Gago M., Novo I., Rodríguez-Segade S. Effects of valproic acid on the urea cycle and carnitine metabolism. Int Pediatr. 1990 ; 5 (1). 54-57.
7. Castro-Gago M., Eiris-Punal J., Novo-Rodrí-guez MI, Couceiro J., Camina F., Rodríguez-Segade S. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. J Child Neurol. 1998 ; 13 (11). 546-549.
8. Schulpis KH, Karikas GA, Tjamouranis J., Regoutas S., Tsakiris S. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia. 2001 ; 42 (10). 1359-1362.
9. Yilmaz Y., Tasdemir HA, Paksu MS The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol. 2008 [Epub ahead of print].
10. Korkmazer N., Vurucu S., Demirkaya E., et al. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Brain Dev. 2006 ; 28 (8). 515-520.
11. Arslan M., Vurucu S., Balamtekin N., et al. The effects of biotin supplementation on serum and liver tissue biotinidase activity and alopecia in rats which were administrated to valproic acid. Brain Dev. 2008 [Epub ahead of print].
12. Wolf B., Grier RE, Allen RJ, Goodman SI, Kien CL Biotinidase deficiency: enzymatic defect in late onset multiple carboxylase deficiency. Clin Chim Acta. 1983 ; 131 (3). 273-281.
13. Stanley SJ, Griffin JB, Zempleni J. Biotinylation of histones in human cells. Effects of cell proliferation. Eur J Biochem. 2001 ; 268 (20). 5424-5429.
14. Krause K. -H, Berlit P., Bonjour J-P. Impaired biotin status in anticonvulsant therapy. Ann Neurol. 1982 ; 12 (5). 485-486.
15. Krause K. -H, Kochen W., Berlit P., Bonjour J-P. Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy. Int J Vitam Nutr Res. 1984 ; 54 (2-3). 217-222.
16. Krause K. -H, Bonjour J-P., Berlit P., Kochen W. Biotin status of epileptics. Ann N Y Acad Sci. 1985 ; 447: 297-313.
17. Krause KH, Bonjour JP, Berlit P., Kynast G., Schmidt-Gayk H., Schellenberg B. Effect of long-term treatment with antiepileptic drugs on the vitamin status. Drug Nutr Interact. 1988 ; 5 (4). 317-343.
18. Hymes J., Wolf B. Biotinidase and its roles in biotin metabolism. Clin Chim Acta. 1996 ; 255 (1). 1-11.
19. Grier RE, Heard GS, Watkins P., Wolf B. Low biotinidase activities in the sera of patients with impaired liver function: evidence that the liver is the source of serum biotinidase. Clin Chim Acta. 1990 ; 186 (3). 397-400.
20. Anagnostouli M., Livaniou E., Nyalala JO, et al. Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 ; 99 (6). 387-392.